HomeENBI • CNSX
add
Entheon Biomedical Corp
Previous close
$0.14
Year range
$0.050 - $0.25
Market cap
1.24M CAD
Avg Volume
16.98K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Aug 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 67.28K | -30.25% |
Net income | -64.70K | 31.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Aug 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 228.60K | -40.13% |
Total assets | 249.32K | -42.14% |
Total liabilities | 20.19K | -51.43% |
Total equity | 229.13K | — |
Shares outstanding | 8.86M | — |
Price to book | 4.67 | — |
Return on assets | -57.53% | — |
Return on capital | -64.32% | — |
Cash Flow
Net change in cash
| (CAD) | Aug 2024info | Y/Y change |
|---|---|---|
Net income | -64.70K | 31.79% |
Cash from operations | -70.54K | 36.88% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -70.54K | 35.35% |
Free cash flow | -47.88K | 44.05% |
About
Founded
Jun 2019
Headquarters
Website
Employees
1
